New Current Report Filed with the SEC Disclosing Occurrence of a Material Impairment: 8-K/A – Caladrius Biosciences, Inc. (0000320017) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing the occurrence of a material impairment. Details of the current report are:

8-K/A – Caladrius Biosciences, Inc. (0000320017) (Filer)
Filed: 2016-03-14 AccNo: 0000320017-16-000092 Size: 25 KB

Item 2.05: Cost Associated with Exit or Disposal Activities

Item 2.06: Material Impairments
Filing Date: 2016-03-14T07:20:21-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: